Asthma Clinical Trial
Official title:
Valuation of Quality of Life in Children With Asthma
The aim of the study is valuation of quality of life (QL) in children with asthma and
analysis of the factors that can have influence on it. The clinical problems included into
the aim are to evaluate:
- the correlation between the QL and asthma control
- the utility of the Polish Version of PAQLQ(S) by Juniper, especially the understanding
of each question and it's answers The results of this study can be very helpful in the
future in developing a questionnaires to use in Polish Primary Care, according to which
the investigators would be able to see whether the asthma in our patients is being well
controlled.
Quality of Life in people with asthma is strictly relevant with the correct treatment of the
disease, that is why the correct screening of patient's quality of life, especially in
children, is so important.
Exploring the quality of life (QL), we use different types of questionnaires to obtain a
quantitative result, which we can interpret using a compatible key for it. Pediatric Asthma
Quality of Life Questionnaire with Standardized Activities (PAQLQ(S)) by Juniper is a
reliable measure of the influence of asthma on QL in children. The Polish Version of the
questionnaire is a strict translation of the english one, however it is not completely
validated, which in practice can evince in difficulties in understanding the meaning of the
applied questions, probably because of the difference in the habits of both populations.
The aim of the study is valuation of quality of life (QL) in children with asthma and
analysis of the factors that can have influence on it. The clinical problems included into
the aim are to evaluate:
- the correlation between the QL and asthma control
- the utility of the Polish Version of PAQLQ(S) by Juniper, especially the understanding
of each question and it's answers The results of this study can be very helpful in the
future in developing a questionnaires to use in Polish Primary Care, according to which
we would be able to see whether the asthma in our patients is being well controlled.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|